Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 391 is a member of the zinc finger protein family characterized by the presence of C2H2-type zinc finger motifs that typically mediate binding to DNA in a sequence-specific manner[3][6]. ZNF391 is predicted to function as a DNA-binding transcription factor, regulating gene expression via interaction with promoter or enhancer elements of target genes by RNA polymerase II[3][6][7]. It is localized in the nucleus and, like other zinc finger transcription factors, may have diverse regulatory roles, although there is currently limited evidence for direct disease association or therapeutic targeting of this specific protein[3][7]. Notes: - There is no clear evidence that ZNF391 is a direct therapeutic target, interacts with drugs, or is currently used as a biomarker or presents notable therapeutic safety concerns[3][7]. - Functional annotation is based on predicted activity from protein domain analysis and gene ontology data, common for less-characterized zinc finger proteins[3][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 391 (ZNF391).